Literature DB >> 31061093

GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.

Dhong Hyo Kho1, Mohammed Hafiz Uddin1, Madhumita Chatterjee1, Andreas Vogt2, Avraham Raz1, Gen Sheng Wu3.   

Abstract

GP78 is an autocrine motility factor (AMF) receptor (AMFR) with E3 ubiquitin ligase activity that plays a significant role in tumor cell proliferation, motility, and metastasis. Aberrant extracellular signal-regulated kinase (ERK) activation via receptor tyrosine kinases promotes tumor proliferation and invasion. The activation of GP78 leads to ERK activation, but its underlying mechanism is not fully understood. Here, we show that GP78 is required for epidermal growth factor receptor (EGFR)-mediated ERK activation. On one hand, GP78 interacts with and promotes the ubiquitination and subsequent degradation of dual-specificity phosphatase 1 (DUSP1), an endogenous negative regulator of mitogen-activated protein kinases (MAPKs), resulting in ERK activation. On the other hand, GP78 maintains the activation status of EGFR, as evidenced by the fact that EGF fails to induce EGFR phosphorylation in GP78-deficient cells. By the regulation of both EGFR and ERK activation, GP78 promotes cell proliferation, motility, and invasion. Therefore, this study identifies a previously unknown signaling pathway by which GP78 stimulates ERK activation via DUSP1 degradation to mediate EGFR-dependent cancer cell proliferation and invasion.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  DUSP1; EGFR; ERK; GP78; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31061093      PMCID: PMC6517599          DOI: 10.1128/MCB.00485-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  gp78: a multifaceted ubiquitin ligase that integrates a unique protein degradation pathway from the endoplasmic reticulum.

Authors:  Zhiliang Chen; Shaojun Du; Shengyun Fang
Journal:  Curr Protein Pept Sci       Date:  2012-08       Impact factor: 3.272

2.  Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1).

Authors:  P S Shapiro; N G Ahn
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

3.  Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.

Authors:  Andrew M Kidger; Linda K Rushworth; Julia Stellzig; Jane Davidson; Christopher J Bryant; Cassidy Bayley; Edward Caddye; Tim Rogers; Stephen M Keyse; Christopher J Caunt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-04       Impact factor: 11.205

Review 4.  Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.

Authors:  Gen Sheng Wu
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 5.  The role of autocrine motility factor in tumor and tumor microenvironment.

Authors:  Tatsuyoshi Funasaka; Avraham Raz
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  Autocrine motility factor modulates EGF-mediated invasion signaling.

Authors:  Dhong Hyo Kho; Tianpeng Zhang; Vitaly Balan; Yi Wang; Seung-Wook Ha; Youming Xie; Avraham Raz
Journal:  Cancer Res       Date:  2014-02-27       Impact factor: 12.701

7.  Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy.

Authors:  Juan Wang; Jun-Ying Zhou; Dhonghyo Kho; John J Reiners; Gen Sheng Wu
Journal:  Autophagy       Date:  2016-07-26       Impact factor: 16.016

Review 8.  Autocrine motility factor receptor: a clinical review.

Authors:  Connie G Chiu; Pascal St-Pierre; Ivan R Nabi; Sam M Wiseman
Journal:  Expert Rev Anticancer Ther       Date:  2008-02       Impact factor: 4.512

9.  The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.

Authors:  Yien Che Tsai; Arnulfo Mendoza; Jennifer M Mariano; Ming Zhou; Zlatka Kostova; Bo Chen; Timothy Veenstra; Stephen M Hewitt; Lee J Helman; Chand Khanna; Allan M Weissman
Journal:  Nat Med       Date:  2007-11-25       Impact factor: 53.440

10.  Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.

Authors:  Federico Rojo; Irene González-Navarrete; Rafael Bragado; Alba Dalmases; Silvia Menéndez; Maria Cortes-Sempere; Cristina Suárez; Cristina Oliva; Sonia Servitja; Vanesa Rodriguez-Fanjul; Isabel Sánchez-Pérez; Clara Campas; Josep Maria Corominas; Ignasi Tusquets; Beatriz Bellosillo; Sergi Serrano; Rosario Perona; Ana Rovira; Joan Albanell
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

View more
  3 in total

1.  Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race.

Authors:  Sandeep K Singhal; Jung S Byun; Tingfen Yan; Ryan Yancey; Ambar Caban; Sara Gil Hernandez; Sediqua Bufford; Stephen M Hewitt; Joy Winfield; Jaya Pradhan; Vesco Mustkov; Jasmine A McDonald; Eliseo J Pérez-Stable; Anna María Nápoles; Nasreen Vohra; Adriana De Siervi; Clayton Yates; Melissa B Davis; Mei Yang; Yien Che Tsai; Allan M Weissman; Kevin Gardner
Journal:  JCI Insight       Date:  2022-07-08

2.  A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.

Authors:  Lanlan Li; Mingfei Yang; Jia Yu; Sha Cheng; Mashaal Ahmad; Caihong Wu; Xinwei Wan; Bixue Xu; Yaacov Ben-David; Heng Luo
Journal:  Int J Mol Sci       Date:  2022-09-18       Impact factor: 6.208

3.  Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer.

Authors:  Desirée Martínez-Martínez; María-Val Toledo Lobo; Pablo Baquero; Santiago Ropero; Javier C Angulo; Antonio Chiloeches; Marina Lasa
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.